Clinical Trial: A Study of EBC-129 in Advanced Solid Tumours
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Solid Tumours
Study Type: INTERVENTIONAL
Official Title: A Phase 1A/B Study To Evaluate The Safety And Tolerability Of EBC-129 As A Single Agent And In Combination With Pembrolizumab In Advanced Solid Tumours
Brief Summary:
This study will assess the safety and tolerability of EBC-129 as a single agent and in combination with pembrolizumab in patients with advanced solid tumours
Read more